Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and care teams, and patients.
The new company will use established digital technology solutions to streamline clinical trial design and delivery in order...
Health technology company PicnicHealth announced it is moving into the oncology space and teaming up with AstraZeneca to build a registry to generate real-world data on breast cancer.
The company says it will work with people living with cancer to collect and structure their medical records data to advance oncology research using robust datasets.
Additionally, the California-based company...
Indonesian digital pharmacy Lifepack scores $7M in Series A funding
Lifepack, a digital pharmacy in Indonesia, has raised $7 million in a Series A funding round led by Golden Gate Ventures.
Launched in 2020, the mobile health platform offers quality and cheap medicines, including over-the-counter drugs, general supplements, and medication for chronic illnesses. Available on Android and iOS...
Digital chronic disease management platform Health2Sync has signed a memorandum of understanding with pharmaceutical firm AstraZeneca to launch a digital patient management programme for patients with chronic kidney disease.
The digital programme seeks to promote the early diagnosis of CKD and optimise everyday CKD care using Health2Sync's patient management platform.
According to a media release...
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.
However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...
AstraZeneca and the Royal Academy of Engineering today (6 Oct) announced a partnership to help drive the development of health tech solutions in Africa.
The joint venture aims to establish connections between African healthcare innovators and AstraZeneca’s A.Catalyst Network, the pharma giant’s new platform with more than 20 global health innovation hubs.
In 2014 the Royal Academy of Engineering...
Pharma giant AstraZeneca is providing a new platform for innovators to discuss health innovation insights through interactive founder roundtables.
The first of two virtual events last week, in collaboration with startup event organisers Slush, explored how innovation can help rebuild healthcare. It also highlighted how collaboration improve patient outcomes and address unmet needs.
New startups...
The pharma world is now looking to digital tools to help facilitate everything from patient adherence to decentralized clinical trials. AstraZeneca has been in the digital game for some time. The life science giant recently teamed up with health system Mass General Brigham to help create and clinically validate patient-centric digital health solutions.
The collaboration used the pharma company’s...
The decentralized research organization Care Access Research has teamed up with AstraZeneca to support the Phase III clinical trial for AZD7442, AstraZeneca’s long-acting monoclonal antibody combination for the potential prevention of COVID-19.
Using Care Access’s Mobile Sites On Demand, the two will develop, deploy and manage clinical research sites across the country to assess the safety and...
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](https://www.mobihealthnews.com/sites/default/files/styles/230x130/public/(Left) Ed Deng%2C Co-founder and CEO of Health2Sync and (Right) Claudio Longo%2C President of AstraZeneca Taiwan.jpg?itok=O1YqUgdy)
_9.JPG?itok=yNwUpNTb)
